Ping Xu

机构：Peking University, Wenzhou Medical University, China Animal Disease Control Center, Zhejiang Cancer Hospital, Chengdu Military General Hospital, Shanghai Public Health Clinical Center, Hubei University of Arts and Science, Xiangyang Central Hospital, Hangzhou Academy of Agricultural Sciences, Chungnam National University Hospital, First Affiliated Hospital of Henan University, First Affiliated Hospital of Jinan University, Hangzhou Cancer Hospital, Chongqing Jiaotong University · ORCID：0000-0003-2455-6647

发表论文 170 篇 · 总被引 3994 次 · h-index 32

代表论文

• Deubiquitinase OTUD5 as a Novel Protector against 4‐HNE‐Triggered Ferroptosis in Myocardial Ischemia/Reperfusion Injury (2023 · Advanced Science · 被引 117)
• Dual degradation mechanism of GPX4 degrader in induction of ferroptosis exerting anti-resistant tumor effect (2022 · European Journal of Medicinal Chemistry · 被引 54)
• Structure-activity relationship study of RSL3-based GPX4 degraders and its potential noncovalent optimization (2023 · European Journal of Medicinal Chemistry · 被引 42)
• ALDH2 deficiency augments atherosclerosis through the USP14-cGAS-dependent polarization of proinflammatory macrophages (2024 · Redox Biology · 被引 27)
• Discovery of Coumarin-Based MEK1/2 PROTAC Effective in Human Cancer Cells (2022 · ACS Medicinal Chemistry Letters · 被引 20)
• Herbal dual-network hydrogel: A programmed release for enhanced scarless wound healing (2025 · Chemical Engineering Journal · 被引 15)